PharmaMar Oncology

PharmaMar Oncology is owned by PharmaMar.

View the org chart displaying its 10 main executives

Most searched biographies at PharmaMar Oncology

• Luis Mora, Managing Director
• Elisa Borrego, Director of Public Relations
• Carmen Cuevas, Director, Research and Development

Create your alert
to follow the executive moves at PharmaMar Oncology.

PharmaMar has 1,865 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by PharmaMar Oncology

Social media about PharmaMar Oncology

• PharmaMar Oncology on Wikipedia, Google News & Yahoo Finance
• PharmaMar Oncology on LinkedIn, Twitter & YouTube

Contact by email its executives including Luis Mora

Call PharmaMar Oncology at +34 91...

View the org chart

Register to receive your alert

Report an error